Rein Therapeutics向SEC提交招股说明书 拟出售多达1000万股普通股

美股速递
Sep 04, 2025

Rein Therapeutics向美国证券交易委员会(SEC)提交了招股说明书,该文件涉及股东拟出售多达1000万股普通股的要约和销售事宜。

根据SEC文件显示,此次股票出售将由现有股东进行,涉及的股票数量高达1000万股普通股。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10